Efficient preparation of 6-[18F]fluoroveratraldehyde, the precursor of the multi-step synthesis of [18F]FDOPA

被引:5
|
作者
Al-Labadi, A
Zeller, KP
Machulla, HJ
机构
[1] Univ Klinikum Tubingen, PET Zentrum, D-72076 Tubingen, Germany
[2] Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany
关键词
F-18] labelling; 6-[F-18]fluoroveratraldehyde; F-18]DOPA; nucleophilic aromatic substitution;
D O I
10.1524/ract.2006.94.3.143
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
As a clinically well established PET tracer, 6[F-18]fluoro-L-dopa is prepared by a multi-step synthesis if [F-18]fluoride is to be used for labelling. The [F-18] label is introduced in the first step, i.e. 6-[F-18]fluoroveratraldehyde is prepared first with yields reported in the literature ranging between 20 and 50%. To obtain higher over-all yields in the synthesis of 6-[F-18]fluoro-L-dopa, the F-18 incorporation in the first step was optimised by determining the yield dependencies on solvent, concentration of the precursor, temperature and time of the reaction. Thus, the product is formed with a yield of 89 +/- 2% (n = 15) when using 20 mg of 6-nitroveratraldehyde in 1 mL DMF at 140 degrees C within a reaction time of 10 min.
引用
收藏
页码:143 / 146
页数:4
相关论文
共 50 条
  • [21] Comparison of 6-[18F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism
    Enrico Michler
    Daniel Kaiser
    Kiriaki Eleftheriadou
    Björn Falkenburger
    Jörg Kotzerke
    Sebastian Hoberück
    EJNMMI Research, 11
  • [22] Modification of the automatic synthesis method for [18F]-FDOPA production
    Antuganov, Dmitrii
    Ryzhkova, Daria
    Zykova, Tatiana
    Vinal'ev, Andrey
    Antuganova, Yulia
    Samburov, Oleg
    Zykov, Mikhail
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2017, 60 : S457 - S457
  • [23] Comparison of 6-[18F]FDOPA PET with Nigrosome 1 detection in patients with parkinsonism
    Michler, Enrico
    Kaiser, Daniel
    Eleftheriadou, Kiriaki
    Falkenburger, Bjorn
    Kotzerke, Jorg
    Hoberuck, Sebastian
    EJNMMI RESEARCH, 2021, 11 (01)
  • [24] [18F]Fluorination of an arylboronic ester using [18F]selectfluor bis(triflate): application to 6-[18F]fluoro-L-DOPA
    Stenhagen, Ida S. R.
    Kirjavainen, Anna K.
    Forsback, Sarita J.
    Jorgensen, Charlotte G.
    Robins, Edward G.
    Luthra, Sajinder K.
    Solin, Olof
    Gouverneur, Veronique
    CHEMICAL COMMUNICATIONS, 2013, 49 (14) : 1386 - 1388
  • [25] New rapid fluorination process for the production of carrier free-F-18 6-[18F]FDA and 6-[18F]-L-DOPA
    Neumann, Kiel
    Qin, Linlin
    Vavere, Amy
    Snyder, Scott
    DiMagno, Stephen
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [26] Automated synthesis of [18F]Raltegravir through [18F]fluorobenzylamine
    Blecha, Joseph
    Neumann, Kiel
    VanBrocklin, Henry
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [27] One step synthesis of N-succidimidyl-4-[18F]-fluorobenzoate ([18F]SFB)
    Petersen, Ida
    Kjaer, Andreas
    Herth, Matthias
    Madsen, Jacob
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S201 - S201
  • [28] A within-subject comparison of 6-[18F]Fluoro-m-Tyrosine (FMT) and 6-[18F]Fluoro-l-DOPA (FDOPA) in Parkinson disease (PD)
    Gallagher, Catherine L.
    Holden, James
    Christian, Brad
    Harding, Sandra
    Nickles, Robert J.
    Johnson, Sterling
    NEUROIMAGE, 2010, 52 : S75 - S75
  • [29] Rapid, high-yield enzymatic synthesis of n.c.a. 6-[18F]fluorodopamine (6-[18F]FDA) for in vivo application
    Bamminger, Karsten
    Raitanen, Julia
    Karanikas, Georgios
    Rasul, Sazan
    Nics, Lukas
    Mitterhauser, Markus
    Wadsak, Wolfgang
    Hacker, Marcus
    Pichler, Verena
    Vraka, Chrysoula
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 114 : 189 - 197
  • [30] Rapid high-yield enzymatic synthesis of n.c.a. 6-[18F] fluorodopamine (6-[18F]FDA) for in vivo application
    Bamminger, K.
    Plank, C.
    Raitanen, J.
    Karanikas, G.
    Rasul, S.
    Nics, L.
    Mitterhauser, M.
    Wadsak, W.
    Hacker, M.
    Pichler, V.
    Vraka, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S240 - S240